CryoXtract Blog

On the Conference Circuit: WRIB 2016

Posted by Graham Long on Apr 21, 2016 8:18:18 AM

With over 700 bioanalytical researchers from major pharmaceutical companies and CROs, this year's Workshop on Recent Issues in Bioanalysis held in Orlando, FL through Thursday of this week is an exciting place for CryoXtract to be exhibiting! Stop by Booth #47 to learn how CryoXtract’s frozen sample aliquotters help preserve the integrity and accuracy of data from bioanalysis in drug discovery and development. 

Read More

Topics: bioanalysis, WRIB

In the News: FFPE or Frozen?

Posted by Marie Gouin on Mar 2, 2016 2:03:05 PM

In bioanalysis of tissue specimens, there are two main options for long-term sample storage: formalin-fixed paraffin-embedded (FFPE) samples and frozen samples. An editorial article by Caitlin Smith, (found herenicely outlines the benefits and detriments of each. Though FFPE samples are preferred for immunostaining and morphology, she concludes that frozen samples are preferable to FFPE samples for molecular analysis and native morphology for several reasons. Foremost among them is the higher potential for quality degradation during preparation and storage. Frozen specimens, which do not suffer the same degradation, are particularly necessary for analyses involving mass spectrometry, quantatative real-time PCR, and Western blotting. 

Read More

Topics: frozen aliquotting, bioanalysis, molecular analysis

CryoXtract is Finalist for the SLAS Innovation Award

Posted by Graham Long on Jan 6, 2016 7:46:06 AM

CryoXtract Instruments, LLC will be offering a podium presentation and exhibiting at the Society for Laboratory Automation and Screening (SLAS) annual conference from January 24th-27th in San Diego. CryoXtract is also pleased to announce that their abstract was one of only 9 finalists selected for the SLAS Innovation Award. The $10,000 award is bestowed upon the podium presentation that is "exceedingly innovative and contributes to the exploration of technologies in the laboratory, exceeds a benchmark or milestone in screening or the lead discovery process, or demonstrates an advanced and integrated use of mature technologies." 

Read More

Topics: frozen aliquotting, bioanalysis, DMPK, LC-MS/MS, slas